Based on imaging mass spectrometry analysis, Rauser’s study found that CRIP1 and HER2 show co-expression or highly correlated spatial distribution in tissues, and CRIP1 is significantly upregulated in HER2-positive breast cancer. Here, ERBB2 is linked to breast carcinoma.